|
Originally published In Press as doi:10.1074/jbc.M208076200 on December 4, 2002
J. Biol. Chem., Vol. 278, Issue 9, 7431-7438, February 28, 2003
Peroxisome Proliferator-activated Receptor and Transforming Growth Factor- Pathways Inhibit Intestinal
Epithelial Cell Growth by Regulating Levels of TSC-22*
Rajnish A.
Gupta ,
Pasha
Sarraf§,
Jeffrey A.
Brockman¶,
Scott B.
Shappell ,
Laurel A.
Raftery** ,
Timothy
M.
Willson§§, and
Raymond N.
DuBois ¶¶
From the Departments of ¶¶ Medicine,
Cellular and Developmental Biology, and Pathology,
Vanderbilt University Medical Center, Nashville, Tennessee 37232, the
§ Dana-Farber Cancer Institute and Department of Cell
Biology, Harvard Medical School, Boston, Massachusetts 02115, ¶ Psychiatric Genomics, Inc., Gaithersburg, Maryland 20878, ** Cutaneous Biology Research Center, Massachusetts General
Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, and §§ Nuclear Receptor Discovery Research,
GlaxoSmithKline, Research Triangle Park, North Carolina 27709
Peroxisome proliferator-activated
receptor (PPAR ) and transforming growth factor- (TGF- ) are
key regulators of epithelial cell biology. However, the molecular
mechanisms by which either pathway induces growth inhibition and
differentiation are incompletely understood. We have identified
transforming growth factor-simulated clone-22
(TSC-22) as a target gene of both pathways in
intestinal epithelial cells. TSC-22 is member of a family of leucine
zipper containing transcription factors with repressor activity.
Although little is known regarding its function in mammals, the
Drosophila homolog of TSC-22,
bunched, plays an essential role in fly development. The
ability of PPAR to induce TSC-22 was not dependent on an intact
TGF- 1 signaling pathway and was specific for the isoform. Localization studies revealed that TSC-22 mRNA is enriched in the
postmitotic epithelial compartment of the normal human colon. Cells
transfected with wild-type TSC-22 exhibited reduced growth rates and
increased levels of p21 compared with vector-transfected cells.
Furthermore, transfection with a dominant negative TSC-22 in which both
repressor domains were deleted was able to reverse the p21 induction
and growth inhibition caused by activation of either the PPAR or
TGF- pathways. These results place TSC-22 as an important
downstream component of PPAR and TGF- signaling during
intestinal epithelial cell differentiation.
*
This work was supported in part by United States Public
Health Service Grants RO1DK 47279 (to R. N. D.), P030
ES-00267-29 (to R. N. D.), and P01CA-77839 (to R. N. D.) and is supported by grants from the Shiseido Company of
Japan, Ltd. (to L. A. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

Supported by grants from the American Cancer Society and the
National Institutes of Health.

Recipient of a Veterans Affairs Research Merit Grant, a
Mina C. Wallace Professor of Cancer Prevention, and supported by the T. J. Martell Foundation and National Colorectal Cancer
Research Alliance. To whom correspondence should be addressed:
Dept. of Medicine/GI, MCN C-2104, Vanderbilt University Medical Center, 1161 21st Ave. South, Nashville, TN 37232-2279. Tel.: 615-322-5200; Fax: 615-343-6229; E-mail: raymond.dubois@vanderbilt.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. W. Fetterman Jr. and M. M. Zdanowicz
Therapeutic potential of n-3 polyunsaturated fatty acids in disease
Am. J. Health Syst. Pharm.,
July 1, 2009;
66(13):
1169 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yu, M. Ershler, L. Yu, M. Wei, B. Hackanson, A. Yokohama, T. Mitsui, C. Liu, H. Mao, S. Liu, et al.
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia
Blood,
May 28, 2009;
113(22):
5558 - 5567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Necela, W. Su, and E. A. Thompson
Peroxisome Proliferator-activated Receptor {gamma} Down-regulates Follistatin in Intestinal Epithelial Cells through SP1
J. Biol. Chem.,
October 31, 2008;
283(44):
29784 - 29794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wu, M. Yamada-Mabuchi, E. J. Morris, P. S. Tanwar, L. Dobens, S. Gluderer, S. Khan, J. Cao, H. Stocker, E. Hafen, et al.
The Drosophila homolog of human tumor suppressor TSC-22 promotes cellular growth, proliferation, and survival
PNAS,
April 8, 2008;
105(14):
5414 - 5419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Bush, J. M. Havens, B. M. Necela, W. Su, L. Chen, M. Yanagisawa, P. Z. Anastasiadis, R. Guerra, B. A. Luxon, and E. A. Thompson
Functional Genomic Analysis Reveals Cross-talk between Peroxisome Proliferator-activated Receptor {gamma} and Calcium Signaling in Human Colorectal Cancer Cells
J. Biol. Chem.,
August 10, 2007;
282(32):
23387 - 23401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Moibi, D. Gupta, T. L. Jetton, M. Peshavaria, R. Desai, and J. L. Leahy
Peroxisome Proliferator-Activated Receptor-{gamma} Regulates Expression of PDX-1 and NKX6.1 in INS-1 Cells
Diabetes,
January 1, 2007;
56(1):
88 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Barz, A. Hoffmann, M. Panhuysen, and D. Spengler
Peroxisome Proliferator-Activated Receptor {gamma} Is a Zac Target Gene Mediating Zac Antiproliferation
Cancer Res.,
December 15, 2006;
66(24):
11975 - 11982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Perez-Ortiz, P. Tranque, C. F. Vaquero, B. Domingo, F. Molina, S. Calvo, J. Jordan, V. Cena, and J. Llopis
Glitazones Differentially Regulate Primary Astrocyte and Glioma Cell Survival: INVOLVEMENT OF REACTIVE OXYGEN SPECIES AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma}
J. Biol. Chem.,
March 5, 2004;
279(10):
8976 - 8985.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|